Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Biocatalysis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104593463A reveals enzymatic route for high-purity sweetener intermediates with reduced waste and scalable production capabilities.
Patent CN102787147B reveals enzymatic synthesis for L-dihydroorotic acid. Offers high purity, simplified separation, and scalable production for pharmaceutical intermediates.
Patent CN118028274A details a novel acylase mutant enhancing (S)-o-chlorophenylglycine synthesis. This breakthrough offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN107903227B reveals a biocatalytic route for high-purity succinic anhydride derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN1940079A details a novel baker's yeast reduction for synthesizing (2S,3S)-2-benzoyl aminomethyl-3-hydroxy-butyrate, a critical 4-AA precursor, offering mild conditions and high optical purity.
Patent CN112063531B reveals a novel Geotrichum candidum strain for Ticagrelor intermediate synthesis, offering high stereoselectivity and reduced manufacturing costs.
Patent CN109706189B reveals enzymatic route for D-chiro-inositol. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel recombinant (R)-ω-transaminase mutant enables high-yield sitagliptin production with superior stereoselectivity and enzyme activity for pharmaceutical supply chains.
Patent CN103194501B reveals enzymatic synthesis for high purity chiral amino acids. Offers cost reduction and scalable supply for pharmaceutical intermediates manufacturing.
Patent CN119876067B reveals high-activity carbonyl reductase mutants for diltiazem intermediates, offering scalable biocatalytic solutions for pharmaceutical manufacturing.
Novel Yarrowia lipolytica enzyme method for PGF 2α production. Green synthesis ensures high purity and scalable supply chain solutions for global pharmaceutical intermediates manufacturing.
Patent CN105732663B reveals a novel activator boosting 6-APA yield. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN118063351B reveals immobilized enzyme process for high-purity chiral beta-amino acids, offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN100554403C reveals Microbacterium oxydans for high-purity chiral alcohol. Offers cost reduction and supply chain reliability for pharma intermediates.
Novel enzymatic route for high-purity S-Allyl-L-Cysteine from GSAC. Reduces oxidation risks and improves yield for pharmaceutical applications.
Patent CN103898178A details a high-yield enzymatic route for chiral piperidine alcohols, offering significant cost and purity advantages for API manufacturing.
Patent CN108048438B reveals a novel halohydrin dehalogenase mutant for efficient Atorvastatin side chain synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN113717910B details a novel tri-enzyme system for (S)-citronellol synthesis, offering superior selectivity and scalable production for the global fragrance industry.
Patent CN115975969A discloses high-efficiency transaminase mutants for Sitagliptin synthesis, offering superior conversion rates and stability for cost reduction in API manufacturing.
Patent CN116004562A reveals a quadruple transaminase mutant boosting D-4,4'-biphenylalanine production efficiency by 30-fold, offering a scalable, high-purity solution for LCZ696 intermediates.